,trastuzumab deruxtecan
astrazeneca,seagen,gilead sciences,daiichi sankyo
['destiny breast04', 'breast', '$sgen', '$azn', '$gild']
if you're tuning into the #asco22 plenary on destiny breast04 check out 's earlier take on the data -&gt; $azn $dskny $sgen $gild
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.